Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
77,293,683
-
Share change
-
-6,341,106
-
Total reported value
-
$771,377,348
-
Put/Call ratio
-
27%
-
Price per share
-
$9.98
-
Number of holders
-
159
-
Value change
-
-$59,189,140
-
Number of buys
-
106
-
Number of sells
-
52
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q3 2014
As of 30 Sep 2014,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,293,683 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, VANGUARD GROUP INC, Capital World Investors, GOLDMAN SACHS GROUP INC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, Camber Capital Management LLC, State Street Corp, and FRANKLIN RESOURCES INC.
This page lists
159
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.